• Je něco špatně v tomto záznamu ?

Characterization of Three CYP2C19 Gene Variants by MassARRAY and Point of Care Techniques: Experience from a Czech Centre

M. Petrek, L. Kocourkova, V. Zizkova, Z. Nosek, M. Taborsky, J. Petrkova,

. 2016 ; 64 (Suppl 1) : 99-107. [pub] 20170112

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17023366

Distribution of cytochrome P450 2C19 enzyme gene (CYP2C19) variants affecting metabolism of clopidogrel was determined in 526 Czech patients after percutaneous coronary intervention using MassARRAY genotyping and compared to distribution in other populations of European descent. Fifty-three (10%) patients underwent parallel determination of CYP2C19 genotypes from buccal swabs by a point of care technique with 100% concordance to the main genotyping platform. Observed CYP2C19 genotypes were related to clopidogrel metabolism phenotypes and discussed in population context. Hereby, presented methodologies provide accurate CYP2C19 genotyping results in a relatively short time of one up to 12 h and may, therefore, find the relevant place in the field of genotype-guided antiplatelet therapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023366
003      
CZ-PrNML
005      
20170828130814.0
007      
ta
008      
170720s2016 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00005-016-0440-8 $2 doi
035    __
$a (PubMed)28083610
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Petrek, Martin $u Laboratory of Cardiogenomics-LEM, University Hospital Olomouc, Olomouc, Czech Republic. martin.petrek@fnol.cz. Faculty of Medicine and Dentistry, Institute of Molecular and Translational Medicine, Palacký University Olomouc, Olomouc, Czech Republic. martin.petrek@fnol.cz. Department of Pathological Physiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic. martin.petrek@fnol.cz.
245    10
$a Characterization of Three CYP2C19 Gene Variants by MassARRAY and Point of Care Techniques: Experience from a Czech Centre / $c M. Petrek, L. Kocourkova, V. Zizkova, Z. Nosek, M. Taborsky, J. Petrkova,
520    9_
$a Distribution of cytochrome P450 2C19 enzyme gene (CYP2C19) variants affecting metabolism of clopidogrel was determined in 526 Czech patients after percutaneous coronary intervention using MassARRAY genotyping and compared to distribution in other populations of European descent. Fifty-three (10%) patients underwent parallel determination of CYP2C19 genotypes from buccal swabs by a point of care technique with 100% concordance to the main genotyping platform. Observed CYP2C19 genotypes were related to clopidogrel metabolism phenotypes and discussed in population context. Hereby, presented methodologies provide accurate CYP2C19 genotyping results in a relatively short time of one up to 12 h and may, therefore, find the relevant place in the field of genotype-guided antiplatelet therapy.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a cytochrom P450 CYP2C19 $x genetika $7 D065731
650    _2
$a Česká republika $7 D018153
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetická variace $7 D014644
650    _2
$a genotyp $7 D005838
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a sekvenční analýza hybridizací s uspořádaným souborem oligonukleotidů $7 D020411
650    _2
$a koronární angioplastika $x škodlivé účinky $7 D062645
650    _2
$a farmakogenetika $7 D010597
650    _2
$a fenotyp $7 D010641
650    _2
$a inhibitory agregace trombocytů $x terapeutické užití $7 D010975
650    _2
$a vyšetření u lůžka $7 D019095
650    _2
$a tiklopidin $x analogy a deriváty $x terapeutické užití $7 D013988
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kocourkova, Lenka $u Laboratory of Cardiogenomics-LEM, University Hospital Olomouc, Olomouc, Czech Republic. Department of Pathological Physiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic.
700    1_
$a Zizkova, Veronika $u Laboratory of Cardiogenomics-LEM, University Hospital Olomouc, Olomouc, Czech Republic. Department of Pathological Physiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic.
700    1_
$a Nosek, Zdenek $u Department of Pathological Physiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic.
700    1_
$a Taborsky, Milos $u Department of Internal Medicine-Cardiology, Faculty of Medicine and Dentistry, Palacký University and University Hospital Olomouc, Olomouc, Czech Republic.
700    1_
$a Petrkova, Jana $u Department of Pathological Physiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic. jana.petrkova@fnol.cz. Department of Internal Medicine-Cardiology, Faculty of Medicine and Dentistry, Palacký University and University Hospital Olomouc, Olomouc, Czech Republic. jana.petrkova@fnol.cz.
773    0_
$w MED00000581 $t Archivum immunologiae et therapiae experimentalis $x 1661-4917 $g Roč. 64, Suppl 1 (2016), s. 99-107
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28083610 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170828131400 $b ABA008
999    __
$a ok $b bmc $g 1239047 $s 984279
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 64 $c Suppl 1 $d 99-107 $e 20170112 $i 1661-4917 $m Archivum Immunologiae et Therapiae Experimentalis $n Arch Immunol Ther Exp (Warsz) $x MED00000581
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Možnosti archivace